What is the typical initial investment needed for an IV Ketamine Therapy Clinic?

The initial capital expenditure (CAPEX) is approximately $335,000, covering major items like clinic buildout ($150,000) and medical equipment ($45,000 for infusion pumps)

How quickly can an IV Ketamine Therapy Clinic reach profitability?

Based on these assumptions, the clinic is projected to reach operational breakeven quickly, within 2 months of launch, if patient volume targets are defintely met

How much revenue can the clinic generate in the first year?

The projected Year 1 revenue is $1,327,000, growing to $4,098,000 by Year 3, driven by scaling staff and increasing capacity utilization

What is the largest fixed operating expense for the clinic?

The largest fixed expense is the Clinic Facility Lease at $12,000 per month, contributing significantly to the total $19,000 monthly fixed overhead

What is the projected cash requirement before the clinic becomes self-sustaining?

The model shows a minimum cash requirement of $657,000, which occurs in December 2026, covering both initial CAPEX and operational ramp-up

What percentage of revenue is spent on variable costs like supplies and marketing?

Total variable costs, including pharmaceuticals (45%) and marketing (100%), start at 200% of revenue in Year 1, decreasing slightly over time due to efficiency

7 Steps to Write an IV Ketamine Clinic Business Plan (5-Year Forecast)

How to Write a Business Plan for IV Ketamine Therapy Clinic

Follow 7 practical steps to create an IV Ketamine Therapy Clinic business plan in 10-15 pages, with a 5-year forecast, breakeven in 2 months, and initial capital expenditure of $335,000 clearly defined

How to Write a Business Plan for IV Ketamine Therapy Clinic in 7 Steps

#	Step Name	Plan Section	Key Focus	Main Output/Deliverable
1	Define Clinic Concept and Mission	Concept	Legal structure, service packages defined	$925M 5-year revenue goal set for 2030
2	Analyze Patient Demand and Pricing	Market	Validate $1,200 average price point	Forecast 400 monthly treatment sessions starting 2026
3	Detail Facility and Equipment Needs	Operations	Specify $335k initial CAPEX ($45k pumps)	Outline clinic layout and security protocols
4	Structure the Clinical Team and Wages	Team	Document Year 1 salary burden: $890,000	Map 2030 staffing goal (4 NPs, 6 RNs)
5	Develop Referral and Patient Acquisition Strategy	Marketing/Sales	Budget 10% of Year 1 revenue for outreach	Detail utilization increase from 40% to 85%
6	Calculate Costs and Breakeven Point	Financials	Define $19k monthly fixed expense, 20% variable ratio	Confirm early breakeven target of 2 months
7	Finalize Funding Request and Projections	Financials	5-year forecast: $13M Y1 revenue to $92M Y5	Calculate $657k minimum cash need, 949% IRR

What is the true addressable market size for IV Ketamine Therapy in your target region?

The true addressable market for the IV Ketamine Therapy Clinic is found by segmenting local adults with treatment-resistant depression and chronic pain, then validating projected revenue against what patients actually pay, whether through self-pay or insurance contracts; this sets the ceiling for your revenue potential, but you must also check operational constraints, which is why understanding costs is key, so review What Are IV Ketamine Therapy Clinic Operating Costs? to understand the floor.

Quantify Patient Segments

Define the pool of adults with Major Depressive Disorder (MDD).
Isolate the subset suffering from complex chronic pain syndromes.
Estimate the percentage of these groups who have failed conventional therapy.
Factor in local demographics; if your region has 500,000 adults, a 1% target penetration is 5,000 potential patients.

Validate Pricing Assumptions

Determine the standard self-pay rate, perhaps $650 per infusion session.
Check reimbursement rates for specific CPT codes from major local payers.
If the average patient needs 6 initial sessions, the Lifetime Value (LTV) calculation changes fast.
We need to know if the market will defintely support a $4,000 initial treatment package.

Assess Competitor Capacity

List all existing IV Ketamine Therapy Clinics in a 25-mile radius.
Call competitors to check wait times for a first consultation appointment.
If the average wait is over 10 days, supply is constrained, boosting your TAM potential.
Calculate total available infusion chairs across all local competitors per week.

Determine Market Saturation

If competitors run at 90% capacity, the market is tight.
If capacity is low, your initial growth ramp will be faster.
Focus on the PTSD segment if depression providers are overloaded.
The true TAM is the unmet need, not just the total population count.

How will you manage DEA compliance, staffing ratios, and clinical risk management?

You must nail down staffing levels and security protocols before the first infusion to manage DEA compliance and clinical risk effectively, which directly impacts your long-term profitability; read How Increase Profits For IV Ketamine Therapy Clinic? to see how operational efficiency ties to revenue. For the IV Ketamine Therapy Clinic, Year 1 requires at least 2 RNs and 1 NP to handle volume while you defintely map out every patient step from intake to discharge.

Staffing and Protocol Mapping

Pinpoint exact staffing: 2 RNs, 1 NP for Year 1.
Detail intake, treatment, and discharge procedures.
Protocols must cover every clinical decision point.
Staffing ratios determine treatment capacity limits.

Controlled Substance Security

Budget $12,000 for the DEA Drug Storage Vault.
Security must meet DEA requirements for controlled substances.
Inventory reconciliation needs daily sign-offs.
Compliance failure means immediate operational shutdown.

What is the minimum cash required to cover startup CAPEX and operational losses until profitability?

The minimum cash required to cover startup capital expenditures and operational losses until the business becomes self-sustaining is $657,000, which represents the lowest cash point reached in December 2026.

Covering Initial Outlay

Startup capital expenditures (CAPEX) total $335,000 for clinic build-out.
Working capital must cover operational deficits until revenue stabilizes.
Defintely plan for a 3-month runway beyond the break-even month.

Funding the Cash Trough

The funding target must cover the $657,000 trough in Dec-26.
Determine the optimal debt vs. equity mix to manage dilution and payments.
If you need $400k in equity, you must sell that stake now.

Which services or staff roles are the primary revenue drivers, and how fast can capacity scale?

The revenue engine for the IV Ketamine Therapy Clinic will shift heavily toward lower-cost NP/RN services as utilization scales, requiring careful management of the high-value MD treatments to maintain margin while maximizing throughput. If you're looking at the mechanics of launching this, review the steps in How To Start IV Ketamine Therapy Clinic Business?

Revenue Mix Strategy

MD treatments carry a $1,200 AOV.
NP/RN services handle higher patient volume.
Revenue mix shifts toward lower-cost administration.
High-cost MD time must be strictly managed.

Scaling Throughput

Target utilization: 85% by Year 5.
Current utilization sits at 40-50%.
Scaling from 1 NP to 4 NPs planned.
Utilization gains fund provider expansion costs.

Revenue is driven by balancing the $1,200 AOV from Physician (MD) treatments against the higher volume capacity provided by Nurse Practitioners (NPs) and Registered Nurses (RNs). MD time is your most expensive bottleneck; if MDs only perform 10 treatments per month, their revenue contribution is low, but their cost per procedure is high. To scale revenue defintely, the IV Ketamine Therapy Clinic must push utilization of the lower-cost providers while reserving MDs for complex cases or initial assessments.

Capacity scales directly with provider headcount, but utilization is the key metric for profitability now. Starting at 40-50% utilization means half your clinical capacity sits idle; hitting 85% utilization by Year 5 is critical to support hiring more staff, such as increasing from 1 NP to 4 NPs by 2030. If onboarding takes 14+ days, churn risk rises among new hires waiting for patient flow to normalize. The goal is to ensure that when you hire that third NP, utilization across the whole team is already pushing 75%.

Key Takeaways

Securing $657,000 in total capital is necessary to cover the $335,000 initial CAPEX and achieve the aggressive 2-month breakeven target.
The financial model projects an ambitious Year 1 revenue generation of $13 million, supported by scaling clinical capacity.
Strict adherence to DEA compliance, including specific security measures for controlled substances, is a non-negotiable operational prerequisite.
Successful long-term growth hinges on scaling clinical staffing (e.g., from 1 NP to 4 NPs by 2030) to maximize capacity utilization toward 85%.

Step 1 : Define Clinic Concept and Mission

Structure First

Establishing the legal structure and service tiers is the foundation; fail here, and scaling projections are meaningless. You need to decide if you're operating as an LLC or S-Corp now to manage founder liability and tax exposure defintely. This setup must support two distinct revenue streams: the initial, high-touch induction series and the ongoing, lower-frequency maintenance sessions. These packages drive your capacity planning.

The distinction between induction and maintenance directly impacts utilization rates and physician scheduling. Induction treatments are volume drivers early on, while maintenance ensures long-term patient retention and steady cash flow. Without these definitions, calculating practitioner time allocation becomes guesswork, which destroys accurate cost modeling later.

Setting Scale

Your 5-year revenue goal dictates your entire physical and staffing strategy starting today. Targeting $925 million by 2030 is aggressive and requires immediate planning for multi-site expansion. If you use the established $1,200 average price per treatment (from the demand analysis), you must project needing well over 770,000 treatments annually by that final year. That's not just one clinic.

To support that volume, you must bake in capacity expansion now. This means modeling not just Year 1 staffing (1 MD, 1 NP, 2 RNs) but the necessary growth to support hundreds of thousands of annual sessions. Your early fixed costs of $19,000 per month are irrelevant unless you have a clear, actionable path to that massive scale.

Step 2 : Analyze Patient Demand and Pricing

Demand and Price Lock

Setting the expected volume dictates everything else, from staffing needs to facility size requirements. We must confirm local demand supports the required patient throughput to cover operational expenses. If you need to cover $19,000 in monthly fixed operating expenses (Step 6), achieving volume quickly isn't optional; it's mandatory for survival.

This step locks in your top-line revenue potential by validating the $1,200 average price per MD treatment. This price must hold up against local competition and patient willingness to pay out-of-pocket. Honestly, if the local market can't support the volume needed, hitting 400 sessions monthly by 2026 becomes a major execution risk for the entire model.

Forecasting Volume Levers

To forecast volume, start by mapping the addressable population for treatment-resistant depression and chronic pain in your defined service area. We project starting at 400 sessions per month in 2026. This volume requires capturing a small, but significant, fraction of the severe cases in your target demographic, so market research needs to be precise.

Use the $1,200 AOV (Average Order Value, or price per session) to calculate required revenue benchmarks. If you need $480,000 monthly revenue ($1,200 x 400), that's the benchmark you need to hit that year. What this estimate hides is the ramp time; getting to 400 sessions defintely needs aggressive referral building starting Day 1, not midway through Year 1.

Step 3 : Detail Facility and Equipment Needs

Facility Investment

Initial CAPEX dictates launch readiness and regulatory adherence. You must commit $335,000 upfront to secure the physical space and necessary medical gear. Underfunding this step defintely delays patient intake and strains early working capital reserves.

This spending covers the physical conversion of space into a compliant medical environment. It's a fixed cost that must be accurate; scope creep here means you're short on cash before the first patient arrives. Know your hard costs now.

Capital Breakdown

Focus your initial $335,000 capital expenditure (CAPEX) precisely. The largest chunk, $150,000, is for the facility buildout-think specialized HVAC and private treatment rooms. This must support patient comfort and clinical workflow.

The equipment budget requires $45,000 specifically for infusion pumps; buy reliable, modern units. For layout, plan for distinct zones: reception, secure medication storage, treatment bays, and a monitored recovery area. Security protocols must be robust, especially around controlled substance storage, requiring audited access logs and reinforced physical barriers.

Step 4 : Structure the Clinical Team and Wages

Staffing the Core Capacity

Clinical staffing is the bottleneck for any service-based medical practice. Getting your Year 1 headcount right directly controls your immediate cash burn while setting the ceiling on patient volume. You can't sell treatments you can't safely deliver. Honestly, this team structure is your single largest fixed operating cost commitment early on.

The required Year 1 structure needs 1 MD, 1 NP, and 2 RNs. Factoring in benefits and payroll taxes, this team results in a total salary burden of $890,000 annually. This number needs to be covered by patient revenue before you even think about marketing spend or rent payments. It's the foundation you build everything else upon.

Scaling Headcount Wisely

Don't wait until you are overwhelmed to hire; plan your next clinical hire based on projected volume growth, not just current revenue. You need a clear roadmap showing when you add staff to maintain service quality. The plan maps expansion to 4 NPs and 6 RNs by 2030 to support the aggressive revenue targets.

Tie hiring triggers to utilization. If your existing clinical staff is consistently running above an 85% utilization rate, you need to start the recruitment process immediately. If onboarding takes 14+ days, churn risk rises because you can't meet booked appointments. You defintely want to hire ahead of the curve, but only slightly.

Step 5 : Develop Referral and Patient Acquisition Strategy

Volume Scaling

Getting patients in the door is your primary Year 1 hurdle. You must aggressively fund outreach to move utilization from 40% to 85%. This requires a dual strategy focusing on both digital visibility and trusted professional referrals. If you underspend on marketing, you leave cash on the table by underutilizing expensive clinical staff. It's a direct trade-off between marketing spend and fixed cost absorption, and we can't afford idle capacity.

The challenge here is speed. You start forecasting 400 sessions/month, but you need to scale toward 850 treatments monthly to justify your fixed overhead of $19,000. If onboarding takes 14+ days, churn risk rises because patients seeking rapid relief won't wait. You defintely need clear Service Level Agreements (SLAs) with referring providers.

Acquisition Budget

Allocate 10% of Year 1 revenue-that's $1.3 million-specifically for marketing and referral incentives. This budget must cover digital acquisition (SEO, targeted ads) and direct outreach to primary care physicians and psychiatrists who treat treatment-resistant depression (TRD) and chronic pain. You're paying for access to patients who have exhausted conventional options.

To reach 85% utilization based on the $1,200 average price per treatment, you need to consistently book 850 treatments per month. Your marketing plan must show a clear Cost Per Acquisition (CPA) that allows you to spend $1.3 million and acquire enough recurring patients to sustain that volume. Track the source of every patient; if a referral source costs $100 to acquire but yields a full induction series, it's a winner.

Step 6 : Calculate Costs and Breakeven Point

Cost Structure Check

Understanding your burn rate dictates survival. Fixed costs lock you in, while variable costs scale with sales. Miscalculating these means you won't know when you actually start making money. We need precise numbers to set realistic volume targets for the first quarter. This step is defintely where you find out if the model works.

Hitting Breakeven

Here's the quick math for survival. To cover the $19,000 fixed spend, you need a contribution margin of 80% (100% minus the 20% variable costs). Your required breakeven revenue is $19,000 divided by 0.80, which equals $23,750 monthly. That's the revenue floor.

Since the average treatment price is $1,200, you need about 20 treatments per month to break even. If you hit the initial forecast of 400 sessions/month (Step 2), you clear this threshold easily. This confirms the 2-month breakeven target is achievable if patient acquisition ramps up fast.

You must nail down your operational baseline now. We are looking at $19,000 in monthly fixed operating expenses. This covers salaries (Step 4), rent, and utilities before the first patient walks in the door. Your total variable cost ratio is set low at 20%. That's good news for margin.

Within that 20% variable spend, Cost of Goods Sold (COGS) for the ketamine and supplies makes up 75% of that portion. This means COGS is only 15% of total revenue (0.75 multiplied by 20%). Anyway, that ratio is lean for a medical practice, so watch supply chain costs closely.

Step 7 : Finalize Funding Request and Projections

Locking the Ask

Finalizing projections means locking down the entire financial narrative for investors. This step synthesizes your revenue targets, cost structure, and required runway. If the cash need is too low, you risk running dry before scaling. If the returns look weak, you won't attract the right partners. This is defintely where the plan becomes a concrete ask.

You need to show the exact capital required to hit the growth milestones established in Step 1. This number isn't arbitrary; it's calculated based on the negative cash flow period before you hit breakeven, plus a safety buffer for unexpected delays in patient onboarding.

Show the Return Profile

You must present the full 5-year picture, showing revenue scaling from $13 million in Year 1 to $92 million by Year 5. Make sure the minimum cash requirement, set at $657,000, covers the initial burn period. This level of growth supports a projected Internal Rate of Return (IRR) of 949%.

Here's the quick math on that return: securing $657,000 now yields a massive payoff if you hit those revenue targets. That 949% IRR is what convinces sophisticated capital this specialized medical clinic is worth the risk over a standard investment.